期刊文献+

HER-2在宫颈病变脱落细胞的表达及临床意义 被引量:2

Expression and clinical significance of HER-2 oncogene in cervical lesion cells
下载PDF
导出
摘要 目的:研究癌基因HER-2在不同程度宫颈病变脱落细胞的表达,探讨它在宫颈癌发生发展中的作用及临床意义。方法:用荧光原位杂交(FISH)法检测12例正常宫颈、55例宫颈上皮内瘤变(CIN)及24例浸润性宫颈癌脱落细胞中HER-2的表达。结果:HER-2在正常宫颈脱落细胞中不表达,在CINⅠ、CINⅡ~Ⅲ及宫颈癌的阳性表达率分别为6.3%、25.6%及58.3%。HER-2在CINⅡ~Ⅲ及子宫颈癌组表达均显著高于正常组(P<0.01),同时宫颈癌组HER-2明显高于CIN组(P<0.01)。HER-2高表达与细胞分级明显相关(P<0.01),与临床分期、病理类型无关。结论:HER-2基因高表达在宫颈癌发生发展中可能起重要作用,在宫颈病变脱落细胞中检测HER-2基因对探讨宫颈病变的进展和预测不良预后可能有重要意义。 Objective:To investigate the expression of the HER-2 oncogene in cervical lesion, and to evaluate the clinical significance of HER-2 expression in cervical lesion. Method:The expression of HER-2 in 24 cases with infiltrating cervical cancer,55 cases with cervical intraepithelial neoplasia (CIN) and 12 cases with normal control cervix were detected by the fluorescent in situ hybridization (FISH). Results:The expression of HER-2 was not observed in normal cervix cells. Positive expression rates of the HER-2 in CIN Ⅰ , CIN Ⅱ - Ⅲ and infiltrating cervical cancer cells were 6.3% ,25.6% and 58.3% respectively. Compared with control group, HER-2 expression rate in CIN Ⅱ - Ⅲ and infiltrating cervical cancer was different significantly (P 〈0.01 ) ,and there was a significantly difference between CIN group and infiltrating cervical cancer group(P 〈0.01 ). The over expression of HER-2 was correlated with the differentiation degree of carcinoma closely ( P 〈 0.01 ). No correlation was found between positive expression and clinical stages, nor pathologic types. Conclusion:The over-expression of HER-2 may play an important role in cervical carcinogenesis, it may be recommended to evaluate the progression and predict poor prognosis of cervical lesion.
出处 《现代妇产科进展》 CSCD 北大核心 2009年第1期14-16,21,共4页 Progress in Obstetrics and Gynecology
基金 卫生部医药卫生科技发展中心资助项目(No:WKJ2007-3-001)
关键词 基因HER-2 宫颈肿瘤 荧光原位杂交 宫颈上皮内瘤变 Genes, HER-2 Cervical neoplasms Fluorescence in situ hybridization Cervical intraepithelial neoplasia
  • 相关文献

参考文献13

  • 1凌斌.子宫颈癌诊断与治疗的新进展[J].中国实用妇科与产科杂志,2007,23(1):23-25. 被引量:66
  • 2周颖,凌斌,冯定庆,程志祥,沈国栋,高婷,石永云,王梅梅,赵卫东,祝怀平.针对Her-2基因的小分子干扰RNA对卵巢上皮性癌细胞生物学行为影响的研究[J].中华妇产科杂志,2006,41(12):830-833. 被引量:4
  • 3Narisawa-Satio W, HandaK, Yugawa T, et al. HPV16 E6- mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes [ J ]. Oncogene, 2007, 26:2988-2996.
  • 4Niibe Y, Nakano T, Ohno T, et al. Prognostic significance of c-erbB-2/HER-2 expression in advanced uterine cervical carcinoma with para-aorticlymph node metastasis treated with radiation therapy[ J]. Gynecol Cancer,2003,13: 849-855.
  • 5Heselmeyer-Haddad K, Janz V, Castle PE, et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia [ J ]. Am J Pathol, 2003, 163 : 1405-1416.
  • 6吴家璐,李龙芸.荧光原位杂交技术对胸腔积液间期细胞染色体数目异常的研究[J].癌症进展,2005,3(5):467-470. 被引量:13
  • 7曹贵华,吴小候,张尧,罗春丽.膀胱癌患者尿脱落细胞存活素表达的临床意义[J].中华泌尿外科杂志,2004,25(6):377-379. 被引量:21
  • 8Carreras R, Alameda F, Mancebo G, et al. A study of Ki67, c-erbB2 and cyclin D-1 expression in CIN Ⅰ , CIN Ⅱ - CIN Ⅲ and squamous cell carcinoma of the cervix [ J ]. Histol Histopathol, 2007,22 : 587 -592.
  • 9Benlimame N,He Q,Jie S,et al. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion[ J]. J Cell Biol,2005,171: 505-516.
  • 10Nahta R, Yu D, Hung MC, et al. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer [ J ]. Nat Clin Pract Oncol, 2006,3 : 269-280.

二级参考文献41

  • 1[1]Wolman SR. Application of fluorescence in situ hybridization techniques in cytopathology. Cancer Cytopathol, 1998, 84:193
  • 2[2]Abati A, Sanford JS, Fertsch P, et al, Fluorescence in situ hybridization (HSH): A user's guide to optimal preparation of cytologic specimens. Diagn Cytopathol, 1995, 13:486
  • 3[3]Schenk T, Ackermann J, Brunner C, et al. Detection of chromosomal an euploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients.chest, 1997, 111 (6):1691
  • 4[4]Roka S, Fiegl M, Zojer N, et al. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat, 1998, 48 (2): 125
  • 5[5]Zojer N, Dekan G, Ackermann J, et al. Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridization. Lung Cancer, 2000, 28 (3):225
  • 6[6]Chen Z, Wang DD, Peier A, et al. FISH in the evaluation of pleural and ascitic fluids. Cancer Genet Cytogenet, 1995, 84(2):116
  • 7[7]Cajulis RS, Yu GH, Gokaslan ST, et al. Modified interphase cytogenetics technique as an adjunct in the analysis of atypical cells in body fluids. Diagn Cytopathol, 1997, 16 (4) :331
  • 8[8]Johnson TM, Kuffel DG, Dewald GW. Detection of hyperdiploid malignant cells in pleural effusions with chromosome - specific probes and fluorescence in situ hybridization. Mayo Cliu Proc,1996, 71 (7) :643
  • 9[9]Florentine BD, Sanchez B, Raza A, et al. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides. Cancer, 1997, 81 (5):299
  • 10[10]Fiegl M, Kaufmann H, Zojer N, et al. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol, 2000 Apr, 31(4) :448

共引文献89

同被引文献75

  • 1方静,薛艳,周党侠,苟文丽.EZH2基因在宫颈癌中的表达及其意义[J].西安交通大学学报(医学版),2011,32(6):758-760. 被引量:10
  • 2Levsky JM,Singer RH. Fluorescence in situ hybridization :past, present and future[ J]. J Cell Sci,2003 ;116:2833 - 2838.
  • 3Hopman AH,TheelenW, Hommelberg PP, et al. Genomie integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer [ J ]. J Pathol, 2006,210(4) :412 -4191.
  • 4黄斌 李瑞珍 汤惠茹等.荧光原位杂交检测宫颈脱落细胞中人类染色体末端酶基因的扩增及临床意义.CGP Chinese General Practice,:1646-1649.
  • 5Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis[ J]. Lancet,2004,363 (9421) : 1633 - 1641.
  • 6Nelson LJ. Preimplantation diagnosis [ J ]. Clin Perinatol,2003, 30(1) :67 -80.
  • 7Heselmeyer- Haddad K,Janz V, Casde PE, et al. Dection of genomic amplification of the human telomerase gene( TERC ) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia [ J ]. Am J Pathology,2003,163 (4) : 1405 - 1416.
  • 8Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics2002 [ J]. CA Cancer J Clin,2005 ,55 :74 - 108.
  • 9Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus - induced oncogenesis[ J ]. J Virol, 2004, 78:11451 - 11460.
  • 10Heselmeyer Haddad K, Janz V, Castle PE, et al. Detection of genomic amplificantion of the human telomerase gene(TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia [ J ]. Am J Pathol,2003,163 ( 4 ) : 1405 - 1416.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部